PDPN and breast neoplasm: In contrast, staining with the lymphatic vessel marker Podoplanin showed an opposite pattern with an increased number of peritumoral lymphatic vessels in the ER−tumors, suggesting that NCoR might also inhibit lymphangiogenesis in human breast tumors.